Regeneron Pharmaceuticals
Regeneron is seeking 2027 Summer Interns to join its Regulatory Affairs & Operations teams, where they will help guide how medicines are described to and approved by global health authorities. Interns will support clinical trial submissions, regulatory document formatting, and research on global regulations for diagnostics and digital health. This full-time, onsite or hybrid role runs from May/June through August and offers hands-on experience in a science-driven pharmaceutical environment.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Associate Director Regulatory Affairs, Oncology
GSK plc
Senior Manager, Regulatory Affairs
Transforming Hypertrophic Cardiomyopathy Care
Senior Manager, Regulatory Affairs
Revolution Medicines
Senior Manager, Regulatory Affairs
Revolution Medicines
Director, Global Regulatory Affairs
EVERSANA
Senior Manager, Regulatory Affairs
Revolution Medicines